ApexFlux Biotech Limited is a joint venture established by a Hong Kong–based investment firm in partnership with Xinzhou Biotech and Shengyang Technology. The company is dedicated to advancing cutting-edge bioinformation technologies, with a particular focus on the development of an internationally pioneering natural healing solution based on biological cellular information — known as Compensatory Bioinformation Energy (CBE). Leveraging its proprietary research, ApexFlux Biotech applies these innovations across the rehabilitation, anti-aging, and wellness and healthcare sectors, positioning itself firmly within the broader health industry.

Strategically positioned at the intersection of biotechnology, medical devices, health and wellness, and the beauty industry, ApexFlux Biotech has built an integrated framework that unites production, education, research, and sales. Building on this foundation, the company is steadily evolving into a comprehensive biotechnology group with diversified capabilities spanning investment, supply chain management, research and development, and brand operations.

What we offer is far more than a product. It is:
An ability — to recalibrate the body to its optimal state, whenever it is needed.
An assurance — a safeguard against the disorder of modern living and the silent erosion of health.
A privilege — to be among the first to experience personalized life management in the era of Programmable Health.